Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo

Journal of Experimental Medicine

Volumn 206, Issue 11, 2009, Pages 2365-2379

  Momi, Stefania ^a   Falcinelli, Emanuela ^a   Giannini, Silvia ^a   Ruggeri, Loredana ^a   Cecchetti, Luca ^a   Corazzi, Teresa ^a   Libert, Claude ^b,c   Gresele, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Department of Plant Systems Biology   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; ADRENALIN; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; FEMALE; GENE INACTIVATION; MALE; MMP2 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOGENESIS; ANIMAL; ARTERY; BLOOD CLOTTING PARAMETERS; C57BL MOUSE; DRUG EFFECT; ENZYMOLOGY; GENOTYPE; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; THROMBOCYTE ACTIVATION; THROMBOSIS; ULTRASTRUCTURE;

ANIMALS; ARTERIES; BLOOD PLATELETS; COLLAGEN; EPINEPHRINE; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; PHENOTYPE; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; THROMBOSIS;

EID: 70449711236     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090687     Document Type: Article

References (45)

1. Antonov, J., D.R. Goldstein, A. Oberli, A. Baltzer, M. Pirotta, A. Fleischmann, H.J. Altermatt, and R. Jaggi. 2005. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab. Invest. 85:1040-1050. doi:10.1038/labinvest.3700303
2. Bhatt, D.L. 2007. Intensifying platelet inhibition - navigating between Scylla and Charybdis. N. Engl. J. Med. 357:2078-2081. doi:10.1056/NEJMe0706859
3. Brass, L.F., L. Zhu, and T.J. Stalker. 2008. Novel therapeutic targets at the platelet vascular interface. Arterioscler. Thromb. Vasc. Biol. 28:s43-s50. doi:10.1161/ATVBAHA.107.161026
4. Brecher, G., and E.P. Cronkite. 1950. Morphology and enumeration of human blood platelets. J. Appl. Physiol. 3:365-377.
5. Casscells, W., M. Naghavi, and J.T. Willerson. 2003. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation. 107:2072-2075. doi:10.1161/01.CIR.0000069329.70061.68
6. IIbbeta3. J. Thromb. Haemost. 6:517-523. doi:10.1111/j.1538-7836.2007.02871.x
7. Ciferri, S., C. Emiliani, G. Guglielmini, A. Orlacchio, G.G. Nenci, and P. Gresele. 2000. Platelets release their lysosomal content in vivo in humans upon activation. Thromb. Haemost. 83:157-164.
8. Davì, G., and C. Patrono. 2007. Platelet activation and atherothrombosis. N. Engl. J. Med. 357:2482-2494. doi:10.1056/ NEJMra071014
9. Davì, G., P. Gresele, F. Violi, S. Basili, M. Catalano, C. Giammarresi, R. Volpato, G.G. Nenci, G. Ciabattoni, and C. Patrono. 1997. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation. 96:69-75.
10. Emiliani, C., S. Ciferri, S. Mencarelli, A.M. Mezzasoma, S. Momi, A. Orlacchio, and P. Gresele. 2006. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders. Platelets. 17:20-29. doi:10.1080/09537100500235958
11. Falcinelli, E., G. Guglielmini, M. Torti, and P. Gresele. 2005. Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J. Thromb. Haemost. 3:2526-2535. doi:10.1111/j.1538-7836.2005.01614.x
12. Falcinelli, E., S. Giannini, E. Boschetti, and P. Gresele. 2007. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin. Br. J. Haematol. 138:221-230. doi:10.1111/j.1365-2141.2007.06632.x
13. Galis, Z.S., and J.J. Khatri. 2002. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90:251-262.
14. Galis, Z.S., G.K. Sukhova, M.W. Lark, and P. Libby. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493-2503. doi:10.1172/JCI117619
15. Gresele, P., J. Arnout, H. Deckmyn, E. Huybrechts, G. Pieters, and J. Vermylen. 1987. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. J. Clin. Invest. 80:1435-1445. doi:10.1172/JCI113223
16. Gresele, P., C. Corona, P. Alberti, and G.G. Nenci. 1990. Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression. Thromb. Haemost. 64:80-86.
17. Gresele, P., E. Falcinelli, and S. Momi. 2008a. Platelet priming. In Platelets in Hematologic and Cardiovascular Disorders. P. Gresele, V. Fuster, J.A. Lòpez, C.P. Page, and J. Vermylen, editors. Cambridge University Press, London. 341-367.
18. Gresele, P., E. Falcinelli, and S. Momi. 2008b. Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. Trends Pharmacol. Sci. 29:352-360. doi:10.1016/j.tips.2008.05.002
19. Gresele, P., E. Falcinelli, S. Giannini, P. D'Adamo, A. D'Eustacchio, T. Corazzi, A.M. Mezzasoma, F. Di Bari, G. Guglielmini, L. Cecchetti, et al. 2009. Dominant inheritance of a novel integrin β3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. Haematologica. 94:663-669. doi:10.3324/haematol.2008.002246
20. Hodivala-Dilke, K.M., K.P. McHugh, D.A. Tsakiris, H. Rayburn, D. Crowley, M. Ullman-Culleré, F.P. Ross, B.S. Coller, S. Teitelbaum, and R.O. Hynes. 1999. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103:229-238. doi:10.1172/JCI5487
21. Hojo, Y., U. Ikeda, T. Katsuki, O. Mizuno, H. Fujikawa, and K. Shimada. 2002. Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty. Atherosclerosis. 161:185-192. doi:10.1016/S0021- 9150(01)00615-3
22. Huo, Y., A. Schober, S.B. Forlow, D.F. Smith, M.C. Hyman, S. Jung, D.R. Littman, C. Weber, and K. Ley. 2003. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9:61-67. doi:10.1038/nm810
23. Itoh, T., T. Ikeda, H. Gomi, S. Nakao, T. Suzuki, and S. Itohara. 1997. Unaltered secretion of β-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272:22389-22392. doi:10.1074/jbc.272.36.22389
24. Kabbani, S.S., M.W. Watkins, T. Ashikaga, E.F. Terrien, P.A. Holoch, B.E. Sobel, and D.J. Schneider. 2001. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation. 104:181-186.
25. Kazes, I., I. Elalamy, J.D. Sraer, M. Hatmi, and G. Nguyen. 2000. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Blood. 96:3064-3069.
26. Kikuchi, S., K. Umemura, K. Kondo, A.R. Saniabadi, and M. Nakashima. 1998. Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening. Arterioscler. Thromb. Vasc. Biol. 18:1069-1078.
27. Kleiner, D.E., and W.G. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218:325-329. doi:10.1006/abio.1994.1186
28. Marx, I., O.D. Christophe, P.J. Lenting, A. Rupin, M.O. Vallez, T.J. Verbeuren, and C.V. Denis. 2008. Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa. Blood. 112:603-609. doi:10.1182/blood-2008-02-142943
29. Mathers, C.D., and D. Loncar. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3:e442. doi:10.1371/journal.pmed.0030442
30. Momi, S., S.C. Pitchford, P.F. Alberti, P. Minuz, P. Del Soldato, and P. Gresele. 2005. Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice. Thromb. Haemost. 93:535-543.
31. Patrono, C., G. Ciabattoni, E. Pinca, F. Pugliese, G. Castrucci, A. De Salvo, M.A. Satta, and B.A. Peskar. 1980. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb. Res. 17:317-327. doi:10.1016/0049-3848(80)90066-3
32. Pitchford, S.C., H. Yano, R. Lever, Y. Riffo-Vasquez, S. Ciferri, M.J. Rose, S. Giannini, S. Momi, D. Spina, B. O'Connor, et al. 2003. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112:109-118. doi:10.1067/mai.2003.1514
33. Pitchford, S.C., Y. Riffo-Vasquez, A. Sousa, S. Momi, P. Gresele, D. Spina, and C.P. Page. 2004. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood. 103:639-647. doi:10.1182/blood-2003-05-1707
34. Pitchford, S.C., S. Momi, S. Baglioni, L. Casali, S. Giannini, R. Rossi, C.P. Page, and P. Gresele. 2008. Allergen induces the migration of platelets to lung tissue in allergic asthma. Am. J. Respir. Crit. Care Med. 177:604-612. doi:10.1164/rccm.200702-214OC
35. Podrez, E.A., T.V. Byzova, M. Febbraio, R.G. Salomon, Y. Ma, M. Valiyaveettil, E. Poliakov, M. Sun, P.J. Finton, B.R. Curtis, et al. 2007. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat. Med. 13:1086-1095. doi:10.1038/nm1626
36. Pulcinelli, F.M., P. Gresele, M. Bonuglia, and P.P. Gazzaniga. 1998. Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets. Biochem. Pharmacol. 56:1481-1484. doi:10.1016/S0006-2952(98)00146-4
37. Ruggeri, L., M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, et al. 2002. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 295:2097-2100. doi:10.1126/science.1068440
38. Santos-Martínez, M.J., C. Medina, P. Jurasz, and M.W. Radomski. 2008. Role of metalloproteinases in platelet function. Thromb. Res. 121:535-542. doi:10.1016/j.thromres.2007.06.002
39. Sawicki, G., E. Salas, J. Murat, H. Miszta-Lane, and M.W. Radomski. 1997. Release of gelatinase A during platelet activation mediates aggregation. Nature. 386:616-619. doi:10.1038/386616a0
40. Sawicki, G., E.J. Sanders, E. Salas, M. Wozniak, J. Rodrigo, and M.W. Radomski. 1998. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb. Haemost. 80:836-839.
41. Sixma, J.J., P.G. de Groot, H. van Zanten, and M. IJsseldijk. 1998. A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb. Res. 92:S43-S46. doi:10.1016/S0049-3848(98)00159-5
42. Vezza, R., R. Roberti, G.G. Nenci, and P. Gresele. 1993. Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. Blood. 82:2704-2713.
43. Vezza, R., A.M. Mezzasoma, G. Venditti, and P. Gresele. 2002. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Thromb. Haemost. 87:114-121.
44. Weyrich, A., F. Cipollone, A. Mezzetti, and G. Zimmerman. 2007. Platelets in atherothrombosis: new and evolving roles. Curr. Pharm. Des. 13:1685-1691. doi:10.2174/138161207780831374
45. Wielockx, B., K. Lannoy, S.D. Shapiro, T. Itoh, S. Itohara, J. Vandekerckhove, and C. Libert. 2001. Inhibition of matrix metallo-proteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat. Med. 7:1202-1208. doi:10.1038/nm1101-1202